Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yurong,Peng

第一单位： Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

作者： Yurong,Peng ^[1] ; Zhuo,Li ^[2] ; Yucheng,Fu ^[1] ; Yue,Pan ^[1] ; Yue,Zeng ^[1] ; Junqi,Liu ^[1] ; Chaoyue,Xiao ^[1] ; Yingzhe,Zhang ^[1] ; Yahui,Su ^[3] ; Guoqing,Li ^[3] ; Fang,Wu ^[1]

作者单位： Department of Oncology, the Second Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[1] The Ophthalmologic Center of the Second Xiangya Hospital, Central South University, Changsha, Hunan, China. ^[2] XiangYa School of Public Health, Central South University, Changsha, Hunan, China. ^[3]

关键词 NSCLC adjuvant therapy biomarkers immunotherapy lung cancer neoadjuvant immune monotherapy neoadjuvant therapies perioperative period perioperative immunotherapy

DOI 10.3389/fonc.2023.1163376

PMID 37064096

发布时间 2023-04-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2023年13卷

1163376页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Corrigendum: Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除